Display title | Chemistry:Interferon beta-1a |
Default sort key | Interferon Beta-1a |
Page length (in bytes) | 31,019 |
Namespace ID | 3022 |
Namespace | Chemistry |
Page ID | 321654 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Counted as a content page | Yes |
Page image |  |
HandWiki item ID | None |
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Page creator | imported>S.Timg |
Date of page creation | 04:30, 6 February 2024 |
Latest editor | imported>S.Timg |
Date of latest edit | 04:30, 6 February 2024 |
Total number of edits | 1 |
Recent number of edits (within past 90 days) | 0 |
Recent number of distinct authors | 0 |
Description | Content |
Article description: (description ) This attribute controls the content of the description and og:description elements. | Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. Some research indicates that interferon injections may result in an 18–38% reduction... |